What is the appropriate acute management and investigation for a patient who had a transient ischemic attack with 2‑minute left‑sided numbness and weakness, without speech or visual involvement?

Management of Transient Ischemic Attack with Left-Sided Numbness and Weakness

This patient requires immediate hospitalization, urgent brain and vascular imaging within hours, and dual antiplatelet therapy with aspirin plus clopidogrel initiated within 24 hours if imaging excludes hemorrhage and confirms non-cardioembolic etiology. 1, 2

Immediate Risk Assessment and Triage

This patient meets high-risk criteria requiring urgent evaluation and hospitalization based on:

• ABCD2 score calculation: Clinical features of unilateral weakness = 2 points, plus duration <10 minutes = 0 points, yielding a minimum score of 2 (higher if age ≥60, BP ≥140/90, or diabetes present). 2, 3
• Any TIA within 24-48 hours mandates hospitalization according to the American Heart Association, regardless of ABCD2 score, because up to 10% risk of recurrent stroke exists and 80% of this risk is preventable with urgent treatment. 2, 4
• The 2-minute duration of symptoms does not reduce urgency—treat this as a medical emergency equivalent to acute stroke. 4, 5

Urgent Diagnostic Imaging Protocol (Within Hours)

Brain imaging must be obtained immediately to exclude hemorrhage and detect silent infarcts:

• MRI with DWI, FLAIR, and GRE/SWI is preferred over CT for detecting acute ischemic changes and determining stroke mechanism. 6, 2
• If MRI unavailable or delayed, obtain non-contrast CT immediately—do not delay evaluation waiting for MRI. 6

Vascular imaging of head and neck must be performed urgently:

• CTA, MRA, or carotid duplex ultrasound to assess for carotid stenosis, intracranial stenosis, or other vascular pathology. 6, 2
• The American Society of Neuroradiology emphasizes vascular imaging is critical for treatment decisions and secondary prevention in all TIA patients. 6
• If duplex ultrasound results are unreliable or discordant with clinical suspicion, proceed immediately to CTA or MRA. 2

Cardiac evaluation:

• ECG immediately to screen for atrial fibrillation. 2
• Transthoracic echocardiography has a diagnostic yield of 19.4% for high-risk cardioembolic features (especially patent foramen ovale and reduced ejection fraction ≤40%), with a number needed to test of only 6 patients. 7

Laboratory studies:

• CBC, electrolytes, renal function, lipid panel, glucose, and hemoglobin A1c. 2

Acute Antiplatelet Therapy (Non-Cardioembolic TIA)

If imaging excludes hemorrhage and cardiac workup excludes atrial fibrillation or other cardioembolic source, initiate dual antiplatelet therapy immediately:

Loading doses (Day 1):

• Aspirin 160-325 mg PLUS clopidogrel 300-600 mg. 1

Maintenance phase (Days 2-30):

• Aspirin 75-325 mg daily PLUS clopidogrel 75 mg daily for 21-30 days. 1
• This regimen prevents 15 ischemic strokes per 1,000 patients while causing only 5 major hemorrhages per 1,000 patients. 1
• Meta-analyses demonstrate 32% reduction in 90-day recurrent stroke risk (RR 0.68) without significantly increasing major bleeding when duration is ≤90 days. 1

After 21-30 days, transition to monotherapy:

• Aspirin 50 mg plus extended-release dipyridamole 200 mg twice daily is the preferred long-term regimen according to the American College of Cardiology, as it reduces stroke risk more effectively than aspirin alone. 2
• Alternatively, clopidogrel 75 mg daily as monotherapy is appropriate, particularly for patients with peripheral arterial disease or prior MI. 2

Critical Pitfall: Cardioembolic TIA

If atrial fibrillation or other cardioembolic source is identified, immediately stop clopidogrel and initiate anticoagulation with apixaban or warfarin (target INR 2.5, range 2.0-3.0). 1, 2 Do not use dual antiplatelet therapy in cardioembolic TIA—this is a common and dangerous error.

Carotid Stenosis Management

If imaging reveals 70-99% symptomatic carotid stenosis:

• Carotid endarterectomy should be performed within 2 weeks at centers with perioperative complication rates <6%. 2, 8
• For 50-69% stenosis, surgery may be indicated for older men with recent hemispheric symptoms and irregular/ulcerated plaque, but only at experienced centers. 2

Blood Pressure Management

Do not lower blood pressure acutely in the emergency setting unless severely elevated (>220/120 mmHg).

• Start antihypertensive therapy 7-14 days after TIA with target <140/90 mmHg. 2
• Use ACE inhibitor alone or combined with thiazide diuretic as first-line therapy. 2

Lipid Management

Initiate high-intensity statin therapy immediately:

• Target LDL <70 mg/dL for all patients with atherothrombotic TIA, regardless of baseline cholesterol. 2, 8
• Recheck lipid panel 4-12 weeks after statin optimization to ensure target achieved. 8

Critical Pitfalls to Avoid

• Never delay antiplatelet therapy while awaiting diagnostic workup—start immediately upon TIA diagnosis if no contraindications. 2
• Never continue dual antiplatelet therapy beyond 90 days—long-duration therapy shows no benefit but substantially increases major bleeding risk (RR 2.42). 1
• Never use dual antiplatelet therapy in cardioembolic TIA—anticoagulation is required instead. 1
• Absolute contraindications to dual antiplatelet therapy include severe uncontrolled hypertension, known allergies, hemophilia or bleeding disorders, and active major bleeding. 1

Patient Education

Educate the patient to return immediately if symptoms recur, as this may represent evolving stroke requiring thrombolytic therapy within the 4.5-hour window. 2, 9